Could Ozempic slow the aging process? “A small clinical trial hints that Ozempic might slow aging. After taking the drug for eight months, participants scored three years “younger” on biological age tests, with the biggest gains in brain and immune health,” reports The Doomslayer.
MedPath reports:
Varun Dwaraka from diagnostics company TruDiagnostic in Lexington, Kentucky, led a randomized controlled trial involving 108 people with HIV-associated lipohypertrophy, a condition characterized by excess fat accumulation and accelerated cellular aging. Half the participants received weekly Ozempic injections for 32 weeks, while the other half received a placebo.
The researchers used epigenetic clocks to assess biological aging – sophisticated tools that identify patterns of DNA methylation, chemical tags that affect gene activity and shift predictably with age. These patterns can be accelerated or slowed by lifestyle factors, meaning biological age can differ significantly from chronological age.
“Those on semaglutide became, on average, 3.1 years biologically younger by the end of the study,” Dwaraka reported. The placebo group showed no significant change in biological age over the same period….
Researchers believe the anti-aging effects stem from semaglutide’s ability to improve fat distribution and reduce inflammation, both major drivers of cellular aging.
Artificial intelligence has created new antiobiotics that kill drug-resistant gonorrhea and MRSA.
Artificial intelligence is also being used to generate highly-effective antibodies to fight disease.
Artificial intelligence is detecting cases of prostate cancer and breast cancer that radiologists overlook.
Scientists are using artificial intelligence to identify the trillions of viruses that live within human beings.
